Lv4
798 积分 2025-07-07 加入
Targeted protein degradation: from mechanisms to clinic
2小时前
待确认
Abstract PO3-05-08: Updated results from VERITAC evaluating vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in ER–positive/human epidermal growth factor receptor 2 (HER2)–negative advanced breast cancer
2小时前
已关闭
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
2小时前
待确认
Asymmetric Synthesis of the cis-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation
2小时前
待确认
Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch
3小时前
待确认
Targeted protein degraders crowd into the clinic
3小时前
待确认
Targeted protein degradation: expanding the toolbox
3小时前
待确认
Targeted protein degradation: from mechanisms to clinic
3小时前
待确认
Conquering PROTAC molecular design and drugability
3小时前
待确认
Overview of PROTACs Targeting the Estrogen Receptor: Achievements for Biological and Drug Discovery
4小时前
待确认
皖公网安备34019202002308
